Catalyst Pharmaceuticals, Inc. (CPRX)
26.26
+0.37
(+1.43%)
USD |
NASDAQ |
Apr 17, 16:00
26.34
+0.08
(+0.30%)
After-Hours: 20:00
Catalyst Pharmaceuticals SG&A Expense (Quarterly) : 48.23M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 24.64M |
| ANI Pharmaceuticals, Inc. | 82.79M |
| Inovio Pharmaceuticals, Inc. | 7.215M |
| Indivior Pharmaceuticals, Inc. | 189.00M |
| United Therapeutics Corp. | 160.80M |